Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
79,376,583
-
Number of holders
-
155
-
Total 13F shares, excl. options
-
48,070,649
-
Shares change
-
-580,092
-
Total reported value, excl. options
-
$1,839,011,256
-
Value change
-
-$64,149,034
-
Put/Call ratio
-
70%
-
Number of buys
-
74
-
Number of sells
-
75
-
Price
-
$38.26
Institutional Holders of Akero Therapeutics, Inc. - COMMON STOCK (AKRO) as of Q1 2023
As of 31 Mar 2023 Akero Therapeutics, Inc. - COMMON STOCK (AKRO) had 155 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 48,070,649 shares of stock of the company.
Largest 10 holders included JANUS HENDERSON GROUP PLC, Skorpios Trust, ALKEON CAPITAL MANAGEMENT LLC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, Avidity Partners Management LP, ADAGE CAPITAL PARTNERS GP, L.L.C., BAKER BROS. ADVISORS LP, STATE STREET CORP, and VANGUARD GROUP INC.
This table shows 155 institutional shareholders of the security as of 31 Mar 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.